Digital Health Innovation: Cimas Healthathon 3.0 launches in Zimbabwe to crowdsource ICT solutions for access, affordability, and fragmented data in healthcare. Rare Disease Access: A look at how “forgotten” medicines can fill major gaps for rare conditions when newer options aren’t available or affordable. Pharma Partnerships & Growth: India’s Piyush Goyal invites global pharma to back India’s innovation push, aiming to double the sector over five years. Cancer Care Equity: A Cardiff woman with relapsed leukemia says she has just six months to live and is raising £500,000 for potentially curative treatment abroad. Insurer Coverage Fight: The AHA files an amicus brief challenging Aetna’s “level of severity” policy, arguing it increases admin burden and threatens coverage transparency. Opioid Treatment Rule: DEA finalizes changes removing a waiver requirement for prescribing medications for opioid use disorder treatment. Public Health & Marketing: STOP urges F1 to end tobacco and nicotine sponsorships amid concerns about youth exposure. Drug Safety & Manufacturing: Haleon plans a ₹2,000 crore India manufacturing facility in Madhya Pradesh to expand supply. Cancer Prevention Vaccine: Oxford and Moderna plan a summer trial of an mRNA vaccine for people with Lynch syndrome to target pre-cancer cells. Clinical Trial Spotlight: Phase 3 data highlight survodutide’s fat-loss and liver-fat reductions in obesity and MASLD. Cardio Screening Potential: Mammography may uncover millions of women with breast arterial calcifications who could benefit from preventive cardiology care.